Clinical Trial

Circulating circRNA in Acute Ischemic Stroke

Study acronym: CRAST
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2024 (before its estimated October 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-10-17; most recent amendment 2024-08-04.
Trial Details
NCT Number NCT05098340
Lead Sponsor The Affiliated Hospital of Xuzhou Medical University
Conditions Acute Ischemic Stroke
Enrollment 500 participants
Start Date 2020-10-01
Primary Completion 2024-10-30 (estimated)
Study Completion 2024-10-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-06